Abstract. Background 
obstruction caused by OV (7) . However, these methods have poor sensitivity for diagnosing CCA (8) . Cancer antigen 19-9 (CA19-9) and carcino-embryonic antigen (CEA) are markers most often used to follow CCA progression. CA19-9 has a sensitivity of 50-60% and a specificity of 80% for diagnosing CCA (9) . However, high levels of CEA often are observed in gastrointestinal cancer, especially in colorectal carcinoma (10) . Thus, the need to differentiate CCA associated with OV infection from other types of cancer is of importance in order to provide correct diagnosis and appropriate treatment. To that end, bile is a potential source of essential indicators and reflects the alteration of CCA microenvironment found in patients with OV infection as well as CCA.
To our best knowledge, there is no report of biomarkers from human bile samples for OV-associated CCA. Hence, we used proteomic analyses of the bile to identify potential candidate biomarkers for OV-associated CCA. These data should be useful for the development of diagnostic tools for early detection and monitoring of CCA patients with OV infection.
Materials and Methods
Study subjects and collection of bile samples. Bile samples were collected from patients with obstructive jaundice undergoing endoscopic retrograde cholangiopancreatography at the Department of Surgery, Rajavithi Hospital, Bangkok and Department of Diagnostic Radiology, Udon Thani Cancer Hospital, Udon Thani province and had surgery performed at the Department of Surgery, Udon Thani Cancer Hospital, Udon Thani Province, Thailand, during March 2014 to January 2016. Of the 43 individuals with obstructive jaundice, 28 also had CCA diagnosed by clinical, ultrasound, CT scan and biopsy, and 15 did not have CCA (13 with bile duct stones and two with cholangitis).
Bile samples from CCA and non-CCA patients were divided into four groups based on the presence of OV infection by detection using real-time polymerase chain reaction. The amplification of genomic DNA of OV was carried out using the following primers: forward primer 5'-CAT AAG GTT GAC TAG GAA ACC GGG-3' (position 97-120) and reverse primer 5'-TGT TCT CAG GCA AGT GAG TGT GCT-3' (position 288-310). The primers were designed to amplify a repetitive DNA fragment specific for OV which showed no significant homology to DNA from other parasites (Aksorn et al., unpublished data).
Aliquots of 5-to 10-ml of bile samples were collected from each study participant and the samples were stored at -80˚C until analysis.
The study was approved by the Ethics Committee on Research involving Human Subjects, Rajavithi Hospital (N0.051/2557) and the Ethics Committee on Human Research, Udon Thani Cancer Hospital (N0.4/2557). All participants provided prior written informed consent.
Sample preparation, sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and tryptic digestion. Bile protein concentration was determined by Lowry's method using bovine serum albumin (BSA) as protein standard. An equal amount of pooled bile protein from each group (50 μg each) was separated by 15% SDS-PAGE followed by silver staining (11) . The stained gel was scanned using a GS-710 scanner (Bio-Rad, Hercules, CA, USA) before being stored in 0.1% (v/v) acetic acid. The gel was then sliced into 14 pieces per lane and each piece further cut into smaller pieces (1 mm 3 /piece), placed into a gel plug, dehydrated with 100% acetonitrile (ACN) for 5 min, dried at room temperature for 15 min, then was added to 10 mM ammonium bicarbonate (NH 4 HCO 3 ) containing 10 mM dithiothreitol for 1 hour at room temperature and alkylated with 100 mM iodoacetamide in 10 mM NH 4 HCO 3 for 1 h in the dark. The gel pieces were dehydrated twice in 100% ACN for 5 min each time and then incubated with 10 μl of trypsin solution (10 ng/μl trypsin in 50% ACN in 10 mM NH 4 HCO 3 ) for 20 min at room temperature. A 20 μl aliquot of 30% ACN was added to keep the gel immersed and it was incubated overnight at room temperature. The trypsiniszed peptides were subsequently extracted from the gel three times with 30 μl of 50% ACN in 0.1% formic acid. Finally, the peptide mixture was dried and kept at -80˚C prior to analysis by liquid chromatographytandem mass spectrometry (LC-MS/MS).
LC/MS-MS analysis.
LC/MS-MS for protein quantitation and identification was conducted using the HCTultra PTM Discovery System (Bruker Daltonics, Bremen, Germany) coupled to an UltiMate 3000 LC System (Dionex, Sunnyvale, CA, USA). Peptides were separated on a nanocolumn (PepSwift monolithic column 100 μm i.d. ×50 mm). Eluent A was 0.1% formic acid and eluent B was 80% ACN in water containing 0.1% formic acid. Peptide separation was achieved with a linear gradient from 10% to 70% of eluent B for 13 min at a flow rate of 300 nl/min, including a regeneration and an equilibration step at 90% and 10% eluent B, respectively. Peptide fragment mass spectra were acquired in a data-dependent AutoMS with a scan range of 300-1500 m/z. Three averages, and up to five precursor ions were selected from the MS scan 50-3000 m/z. MS/MS analysis of peptides generated the spectral data for further protein identification against database search.
Data and bioinformatics analyses. MS/MS data were analyzed using DeCyder MS (GE Healthcare, Piscataway, NJ, USA) and submitted to a search employing Mascot software (Matrix Science, London, UK) of the National Center for Biotechnology Information database for protein identification. Database interrogation was for taxonomy (Homo sapiens), enzyme (trypsin), variable modifications (carbamidomethyl, oxidation of methionine residues), mass values (monoisotopic), protein mass (unrestricted), peptide mass tolerance (1 Da), fragment mass tolerance (±0.4 Da), peptide charge state (1+, 2+ and 3+), and mass missed cleavages. For identification, each protein was required to have at least one peptide with an individual mascot score corresponding to a p-value of less than 0.05. In order to determine an appropriate statistical method to assess the differential abundance of proteins, protein fold-changes among the groups were computed using a comparison of the averaged log2 fold change between two groups, e.g. log2 fold-change=log2 (CCA+OV+)-log2 (CCA+OV-). Functional interaction and association among the identified proteins were examined using the precomputed database STITCH Version 5.0 (http://stitch.embl.de/).
Results

OV status and SDS-PAGE analysis of bile proteins. Among 28
CCA cases, seven cases were positive for OV DNA (CCA+OV+) and 21 were OV DNA-negative (CCA+OV-), in vivo 32: 871-878 (2018) and among 15 non-CCA cases, six were OV DNA-positive (CCA-OV+) and nine were OV DNA-negative (CCA-OV-).
As bile may reflect alteration of protein profile found in close proximity to CCA, preliminary assays were carried out to elucidate the bile protein pattern from patients with CCA with and without OV infection in comparison to those who were cancer-free with and without OV infection. Bile samples were pooled before being separated by 15% SDS-PAGE to reduce variation among individual samples and to minimize data in the subsequent bioinformatics analysis. Protein sizes ranged from 14 to 97 kDa. The gel was divided into 14 slices (Figure 1 ). For example, the protein bands in slices 4 and 7 were dominant in CCA+ (CCA+OV+ and CCA+OV-) groups. However, the protein bands in slice 6 were more intense in CCA-(CCA-OV+ and CCA-OV-) groups.
Bile proteomic profiling. Using a proteomics approach, a total of 938 proteins were identified from the four groups of bile samples, with 905, 878, 875 and 890 proteins present in CCA+OV+, CCA+OV-, CCA-OV+ and CCA-OVsamples, respectively. A Venn diagram of proteins common among the four bile groups revealed three proteins to be present in both CCA+OV+ and CCA-OV+ groups, and four proteins in both CCA+OV+ and CCA+OV-groups ( Figure  2 ). It is worth noting that there was no single protein unique to each bile group.
Candidate biomarkers for OV infection. Three proteins found in quantitatively significant amounts in both CCA+OV+ and CCA-OV+ but not in other groups were demonstrated as candidate protein markers of OV infection. The three proteins were aristaless-like homeobox1 isoform X1 (ALX1;gi|530400865), major histocompatibility complex polypeptide-related sequence A (MICA), (gi|1764074) and uncharacterized protein C14orf105 isoform X12 (gi|578825929) (Figure 2 ). Their levels were 2.90-, 7.06-and 3.65-fold higher, respectively, in CCA+OV+ than in CCA-OV+ (Table I) .
Candidate biomarkers for CCA. Four proteins demonstrated as candidates found in both CCA+OV+ and CCA+OV-but not in other groups were immunoglobulin (Ig) heavy chain (gi|4753744), translocated in liposarcoma (TLS;gi|448295), visual system homeobox 2 (VSX2;gi|34365783), and an unnamed protein product (gi|194378026) (Figure 2 ). Their levels were 4.76-, 4.79-, 2.67-and 3.19-fold higher, respectively, in CCA+OV+ than those in CCA+OV- (Table I) .
Interaction map for the identified candidate marker proteins. STITCH Version 5.0 (http://stitch.embl.de/) was employed to identify binding partners for TLS, VSX2, ALX1 and MICA to identify binding partners and generate a protein interaction network. Ig heavy chain, unnamed protein product and uncharacterized protein C14orf105 isoform X12 were not present in the map as they are not included (as expected) in the STITCH database. The map revealed involvement of two out of the four candidate proteins in the interactions of the following factors relevant to CCA tumorigenesis: Epidermal growth factor receptor (EGFR), interferon beta 1 fibroblast (IFNB1), Kirsten rat sarcoma (KRAS), mucin 1 (MUC1), mucin 5AC (MUC5AC), and tumor protein p53 (TP53);and with anticancer drugs: doxorubicin, cisplatin, gemcitabine, 5-fluorouracil, capecitabine, docetaxel, irinotecan, and leucovorin ( Figure 3 
Discussion
CCA is a tumor arising from epithelial cells of the intrahepatic or extrahepatic bile ducts (12) . Endemic areas for liver fluke infection, such as Thailand and China (13) , are also the regions with the highest worldwide incidence of both intrahepatic and extrahepatic CCA. The parasite persists over years and progressively accumulates in the biliary system causing an inflammatory response and an increased risk of CCA (14) . Chronic inflammation and biliary duct cell injury induced by the obstruction of bile flow are two of the main conditions responsible for the development of CCA (15) . In CCA with bile duct obstruction, biliary drainage is introduced to reduce complications (16) . Bile sampling represents a possible opportunity to detect changes in the CCA microenvironment, to understand the molecular and biochemical mechanisms that drive CCA tumor initiation, maintenance and progression (17, 18) . The bile obtained from patients with biliary obstruction is more likely to contain higher concentrations of CCA-associated proteins than serum and, thus, represents an alternative fluid for identifying potential biomarkers of CCA (19) .
Improvement in early detection of cancer is accepted as a key to increase the survival rate of patients with cancer. Advances in technology have provided important and precise tools for disease-specific biomarkers. Proteomics offers an unprecedented opportunity for identifying new biomarkers and therapeutic targets and providing an understanding of the biochemical pathways involved in pathogenesis (20) . Using a shotgun proteomic approach, Kristiansen et al. (25) . In addition, these authors extended their analyses to include a computational analysis of the promoter regions of the proliferation-associated genes. Likewise, the detection of somatic and rare germline mutations has been shown to be a promising tool for understanding the biology and clinical importance of mutation profiles in gallbladder carcinoma (26) .
We used the technique of pooling bile samples before proteomic analysis to reduce the variation among individual samples and minimize the data files subjected to bioinformatics analysis. The advantages of pooling are increased analytical efficiency, with cost and time savings (27) . Even though the presence of higher abundance proteins such as albumin may mask the detection of lower abundance proteins, removal of albumin may also lead to loss of other low abundance proteins, such as small molecular weight cytokines, molecules that may act as biomarkers (28) . Therefore, the total proteins in the present study were retrieved from the crude bile without depletion of high in vivo 32: 871-878 (2018) abundant proteins such albumin. Figure 1 indicates that protein pattern detectable by SDS-PAGE markedly differed among the four groups. Differences between the electrophoretic patterns indicated that cholangiocytes respond to liver fluke infection and development of CCA differently.
Biomarkers were identified based on identifying proteins with expression that differed between the four groups. For candidate proteins for OV infection, ALX1, MICA, and uncharacterized protein C14orf105 isoform X12 were found in both CCA+OV+ and CCA-OV+, but not in other groups. ALX1 plays a role in neuronal and craniofacial development (29) . More recently, ALX1 was also shown to regulate the expression of genes that induce epithelial-to-mesenchymal transition in primary mesenchyme cells and to play a key role in tumor progression and metastasis (30) (31) (32) (33) . However, little is known about ALX1 function in OV infection. MICA is significantly elevated with increasing cancer stage and metastasis (34) . There are a number of studies on the role of MICA in relation to the presence of infectious agents, such viruses, bacteria and parasites. For example, a high level of MICA polymorphisms correlates with advanced liver fibrosis in Schistosoma japonicum infection (35) . In addition, it is associated with susceptibility or progression of several infectious diseases such as dengue fever (36) , tuberculosis (37) and Chagas disease (38) . Currently, no data are available regarding MICA and OV infection as far as we are aware.
The proteins found in both CCA+OV+ and CCA+OV-groups as candidate markers of CCA included immunoglobulin Ig heavy chain, TLS, VSX2 and an unnamed protein product. Studies showed an association between Ig and other cancer types. IgG produced in lung cancer is believed to play a key role in cancer growth and metastasis, with significant clinical implications (39) . IgA, IgE and IgG have been reported in serum and bile samples of patients with opisthorchiasis (40) . In this study, the proteomic data did not identify the class of immunoglobulin and further study will be needed to identify the class of Ig heavy chain associated with CCA. TLS is a functional protein-associated transcription factor which fusesto a heterologous DNA-binding protein, Ewing's sarcoma (EWS) or TATA-binding protein-associated factor 15 (TAF15). TLS has potent transcriptional activation domains, forming abnormal transcriptional factors that induce malignant tumor development (41, 42) . Recently, TLS was found to be associated with neurodegenerative diseases, such as amyotrophic lateral sclerosis and frontotemporal lobar degeneration (43, 44) . VSX2 is thought to act principally as a repressor of transcription, particularly of genes encoding cyclin-dependent kinase inhibitor (p27 KIP1 ) and microphthalmia transcription factor (MITF) (45) . VSX2 gene was most specific at identifying those at risk of colorectal cancer, with a sensitivity of 83% and a specificity of 92% (46) .
Various chemotherapeutic agents, either alone or in combination, have been tested against CCA (47) . In this study, STITCH, Version 5.0 was employed to identify binding partners for the proteins identified and generate a protein interaction network. It is worth noting that cisplatin, docetaxel, doxorubicin, 5-fluorouracil, gemcitabine, and irinotecan directly bind TP53, well known as the 'guardian of the genome' (48), with which both ALX1 and TLS interact, although indirectly.
This study, through application of SDS-PAGE and subsequent identification of bile proteins by means of LC-MS/MS, reports the discovery of potential candidate biomarkers ALX1 (gi|530400865), MICA, uncharacterized protein C14orf105 isoform X12 for OV and Ig heavy chain, TLS, VSX2, and an unnamed protein product (gi|194378026)) for CCA. The protein interaction map further reveals indirect interaction of ALX1 and TLS with tumor protein p53, is the target of a number of anticancer drugs. Further studies are required to validate the potential of these protein sets as biomarkers for their respective disease, and find the means to capitalize the information gleaned from the protein interaction network.
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